| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Aug 2026 | 14 Aug 2026 |
| BOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026. | ||
| Board Meeting | 29 May 2026 | 26 May 2026 |
| ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve In compliance with Regulation 29 and other applicable provisions of LODR Regulations this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026 This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026. This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026. (As Per BSE Announcement Dated on 29.05.2026) | ||
| Board Meeting | 14 Feb 2026 | 17 Feb 2026 |
| Outcome of Board Meeting held on February 14, 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. | ||
| Board Meeting | 14 Nov 2025 | 11 Nov 2025 |
| ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited (standalone and consolidated) Financial Statement for the quarter ended September 30 2025 Outcome of the Board Meeting held on November 14, 2025 to consider and approve un audited (Standalone and Consolidated) Financials of the Company for the quarter and half year ended September 30, 2025 (As per BSE Announcement dated on: 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
